POST-TREATMENT with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injury

Shock

Volumn 37, Issue 1, 2012, Pages 39-46

  Idrovo, Juan Pablo ^a   Yang, Weng Lang ^a,b   Matsuda, Akihisa ^a   Nicastro, Jeffrey ^a   Coppa, Gene F ^a   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

AICAR; carnitine; CPT1; energy metabolism; ischemia reperfusion; Kidney

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE TRIPHOSPHATE; ASPARTATE AMINOTRANSFERASE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; MALONALDEHYDE; NITROGEN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENERGY; ENZYME ACTIVITY; HISTOLOGY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MORPHOLOGY; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

ADENOSINE TRIPHOSPHATE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; DRUG THERAPY, COMBINATION; ENERGY METABOLISM; FATTY ACIDS; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REPERFUSION INJURY; RIBONUCLEOSIDES;

EID: 83655163863     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31823185d7     Document Type: Article

References (37)

1. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 1(1):43-51, 2006.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7):813-818, 2005. (Pubitemid 41175724)
3. Cecka JM, Cho YW, Terasaki PI: Analyses of the UNOS Scientific Renal Transplant Registry at three yearsVearly events affecting transplant success. Transplantation 53(1):59-64, 1992.
4. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14(8):2199-2210, 2003. (Pubitemid 36909930)
5. Portilla D: Energy metabolism and cytotoxicity. Semin Nephrol 23(5):432-438, 2003. (Pubitemid 37176688)
6. Lehninger AL, Nelson DL, Cox MM. Lehninger Principles of Biochemistry. 5th ed. New York: W. H. Freeman, 2008.
7. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J: Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspect Med 25(5-6):495-520, 2004. (Pubitemid 39195073)
8. Steiber A, Kerner J, Hoppel CL: Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25(5-6):455-473, 2004. (Pubitemid 39195071)
9. Sharma S, Black SM: Carnitine homeostasis, mitochondrial function, and cardiovascular disease. Drug Discov Today Dis Mech 6(1-4):e31-e39, 2009.
10. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244(1):1-14, 1997. (Pubitemid 27079689)
11. Hopkins TA, Dyck JR, Lopaschuk GD: AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart. Biochem Soc Trans 31(Pt 1): 207-212, 2003. (Pubitemid 36241429)
12. Sullivan JE, Brocklehurst KJ, Marley AE, Carey F, Carling D, Beri RK: Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett 353(1): 33-36, 1994. (Pubitemid 24312538)
13. Shah KG, Rajan D, Jacob A, Wu R, Krishnasastry K, Nicastro J, Molmenti EP, Coppa GF, Wang P: Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein. J Surg Res 163(1):110-117, 2010.
14. Gorur S, Bagdatoglu OT, Polat G: Protective effect of L-carnitine on renal ischaemia-reperfusion injury in the rat. Cell Biochem Funct 23(3):151-155, 2005. (Pubitemid 40695397)
15. Hosgorler FU, Atila K, Terzi C, Akhisaroglu ST, Oktay G, Kupelioglu A, Ergor G, Saydam S: Carnitine protects the intestine against reperfusion injury in rats. J Surg Res 159(1):603-610, 2010.
16. Fabian TC, Fabian MJ, Yockey JM, Proctor KG: Acadesine and lipopolysaccharide-evoked pulmonary dysfunction after resuscitation from traumatic shock. Surgery 119(3):302-315, 1996. (Pubitemid 26082666)
17. Lee SJ, Chang YK, Na KR, Lee KW, Suh KS, Kim SY, Chang YS, Shin YT, Bang BK: The preconditioning with AICAR protects against subsequent renal ischemia reperfusion injury. Korean J Nephrol 28(2):96-102, 2009.
18. Wong AK, Howie J, Petrie JR, Lang CC: AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin Sci (Lond) 116(8):607-620, 2009.
19. Bieber LL, Abraham T, Helmrath T: A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem 50(2):509-518, 1972.
20. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97(4):1056-1063, 1996. (Pubitemid 26070586)
21. Armstrong D, Browne R: The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 366:43-58, 1994.
22. Yagi K: Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108:101-106, 1998.
23. Gobe G, Willgoss D, Hogg N, Schoch E, Endre Z: Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 56(4): 1299-1304, 1999. (Pubitemid 29451235)
24. Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, et al.: GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 63(3):853-865, 2003. (Pubitemid 36315563)
25. Kunzendorf U, Haase M, Rolver L, Haase-Fielitz A: Novel aspects of pharmacological therapies for acute renal failure. Drugs 70(9):1099-1114, 2010.
26. Sahajwalla CG, Helton ED, Purich ED, Hoppel CL, Cabana BE: Multipledose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci 84(5):627-633, 1995.
27. Bremer J: The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28(5):297-301, 1990. (Pubitemid 20183132)
28. Mister M, Noris M, Szymczuk J, Azzollini N, Aiello S, Abbate M, Trochimowicz L, Gagliardini E, Arduini A, Perico N, et al.: Propionyl-L- carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int 61(3): 1064-1078, 2002. (Pubitemid 34175476)
29. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT: Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1(6):401-408, 2005. (Pubitemid 43960623)
30. Krauss S, Zhang CY, Lowell BB: The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6(3):248-261, 2005. (Pubitemid 40314925)
31. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162(1): 196-203, 1999. (Pubitemid 29420927)
32. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME: Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15(10): 1562-1574, 2000.
33. Goligorsky MS: Immune system in renal injury and repair: burning the candle from both ends? Pharmacol Res 58(2):122-128, 2008.
34. Giri S, Nath N, Smith B, Viollet B, Singh AK, Singh I: 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci 24(2): 479-487, 2004. (Pubitemid 38112379)
35. Jhun BS, Jin Q, Oh YT, Kim SS, Kong Y, Cho YH, Ha J, Baik HH, Kang I: 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 318(2):372-380, 2004. (Pubitemid 38553790)
36. Bai A, Yong M, Ma AG, Ma Y, Weiss CR, Guan Q, Bernstein CN, Peng Z: Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis. J Pharmacol Exp Ther 333(3):717-725, 2010.
37. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y, Abraham E: Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295(3):L497-L504, 2008.